fluindione has been researched along with Atrial Fibrillation in 13 studies
*Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Berland, M; Charuel, E; Giron, A; Lambert, C; Ménini, T; Pereira, B; Poinas, L; Schmidt, J; Vorilhon, P | 1 |
| Anderson, R; Baber, U; Boersma, E; Capranzano, P; Chen, C; Dangas, GD; Duggal, A; Hambrecht, R; Hayashida, K; Hengstenberg, C; Jin, J; Kim, HS; Laeis, P; Lang, I; Lanz, H; López-Otero, D; Mehran, R; Meincke, F; Möllmann, H; Moreno, R; Nombela-Franco, L; Nordbeck, P; Ohlmann, P; Pilgrim, T; Rodés-Cabau, J; Saito, S; Shawl, F; Thiele, H; Unverdorben, M; Valgimigli, M; Van Mieghem, NM; Veltkamp, R; Vranckx, P; Watanabe, Y; Yamamoto, M; Zamorano, JL | 1 |
| Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N | 1 |
| Caré, B; Laroche, JP; Quéré, I; Schved, JF; Valdelièvre, E | 1 |
| Feutry, F; Marliot, G; Pannier, D; Strobbe, G; Villain, A | 1 |
| Ammentorp, B; Darius, H; De Caterina, R; Kirchhof, P; Le Heuzey, JY; Schilling, RJ; Schmitt, J; Zamorano, JL | 1 |
| Annweiler, C; Barberger-Gateau, P; Beauchet, O; Brangier, A; Ferland, G; Rolland, Y | 1 |
| Cordeanu, EM; Gaertner, S; Mirea, C; Stephan, D | 1 |
| Bertrand, M; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M | 1 |
| Daugas, E; Grimaldi, D; Mougenot, B; Ronco, P; Rossert, J | 1 |
| Ansell, J; Caro, J; Drouet, L; Hollowell, J; Martinez-Brotons, F; Pengo, V | 1 |
| Algayres, JP; Béchade, D; Daly, JP; Henrionnet, A | 1 |
| Chaumet-Riffaud, P; Derumeaux, G; Lacomblez, L; Lardoux, H; Lechat, P; Lecompte, T; Maillard, L; Mallet, A; Mas, JL; Mentre, F; Pisica, G; Pousset, F; Raynaud, P; Sanchez, P; Solbes-Latourette, S | 1 |
2 trial(s) available for fluindione and Atrial Fibrillation
| Article | Year |
|---|---|
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Topics: 4-Hydroxycoumarins; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Mortality; Phenindione; Postoperative Complications; Pyridines; Thiazoles; Thromboembolism; Transcatheter Aortic Valve Replacement; Vitamin K | 2021 |
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Humans; Male; Phenindione; Risk Factors; Thromboembolism; Treatment Outcome; Vascular Diseases | 2001 |
11 other study(ies) available for fluindione and Atrial Fibrillation
| Article | Year |
|---|---|
[Comparative study in primary care of the stability of INR in patients treated with warfarin or fluindione for atrial fibrillation. The FLOWER study (FLuindione Or WarfarinE - Result INR)].
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Flowers; Hemorrhage; Humans; International Normalized Ratio; Phenindione; Primary Health Care; Retrospective Studies; Stroke; Warfarin | 2022 |
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K | 2018 |
[Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Topics: Acenocoumarol; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Female; Humans; International Normalized Ratio; Male; Middle Aged; Phenindione; Risk Factors; Sex Factors; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2018 |
First-time prescription of enzalutamide in a patient treated with fluindione and digoxin: serial drug interactions.
Topics: Aged; Atrial Fibrillation; Benzamides; Digoxin; Drug Interactions; Drug Overdose; Drug Substitution; Hematemesis; Humans; International Normalized Ratio; Male; Nitriles; Phenindione; Phenylthiohydantoin; Polypharmacy; Prostatic Neoplasms; Tinzaparin | 2019 |
Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Europe; Female; Humans; Male; Middle Aged; Phenindione; Phenprocoumon; Practice Guidelines as Topic; Registries; Vitamin K; Warfarin; Withholding Treatment | 2014 |
Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients.
Topics: Aged; Aged, 80 and over; Aging; Anticoagulants; Atrial Fibrillation; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Male; Mental Status Schedule; Phenindione; Pilot Projects; Risk Factors; Stroke; Vitamin K | 2015 |
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Electrocardiography; Factor Xa Inhibitors; Female; Humans; Phenindione; Rivaroxaban; Thrombosis; Vitamin K | 2015 |
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Phenindione; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin | 2015 |
Immuno-allergic interstitial nephritis related to fluindione: first biopsy proven cases.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Atrial Fibrillation; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; Kidney Function Tests; Male; Nephritis, Interstitial; Phenindione; Risk Assessment; Severity of Illness Index | 2006 |
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Canada; Cohort Studies; Drug Monitoring; Female; France; Humans; International Normalized Ratio; Italy; Male; Middle Aged; Phenindione; Practice Patterns, Physicians'; Quality of Health Care; Retrospective Studies; Spain; Stroke; Treatment Outcome; United States; Warfarin | 2007 |
[Analysis of a circulating anticoagulant in the course of treatment with an antivitamin K. Importance in a febrile patient].
Topics: Acebutolol; Aged; Anti-Arrhythmia Agents; Antibodies, Antiphospholipid; Anticoagulants; Atrial Fibrillation; Digoxin; Fever of Unknown Origin; Humans; Immunoglobulins; Lupus Coagulation Inhibitor; Male; Phenindione; Q Fever | 2000 |